Respiratory Syncytial Virus Infection: An Illness for All Ages

Department

Medicine

Document Type

Article

Publication Title

Clinics In Chest Medicine

Abstract

Respiratory syncytial virus (RSV) is the single most important cause of severe respiratory infection in very young infants. It has also been recently recognized as a significant cause of severe illness in elderly adults, those with underlying cardiopulmonary disease, and the immunocompromised. RSV is suspected of playing a major role in the development of asthma. Prophylaxis in high-risk infants using a monoclonal antibody is the only effective specific therapy available but recent breakthroughs in vaccine design and antiviral drugs offer the promise of effective prophylactic and therapeutic agents against RSV.

First Page

29

Last Page

36

DOI

10.1016/j.ccm.2016.11.010

Volume

38

Issue

1

Publication Date

3-1-2017

Medical Subject Headings

Adolescent; Adult; Antiviral Agents (therapeutic use); Child; Child, Preschool; Humans; Infant; Infant, Newborn; Respiratory Syncytial Virus Infections (diagnosis, pathology); Young Adult

PubMed ID

28159159

Share

COinS